Our prior studies implicated adipose-derived FGF1 in the obesity-driven growth of ER-positive breast tumors [9, 34]; therefore, we hypothesized that altered signaling downstream of FGF1 may influence the differential responses of tumors to estrogen deprivation in the context of obesity. The gene discussed is FGF1; the disease is obesity disorder.